300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Social Impact
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Hospitality
Automotive
Sports
Biotechnology
Legal
Consumer
Software
eSports
Construction
Crowdfunding
Renewable Energy
Venture Capital
Theatre
Fashion
Medical
Recruiting
Social
Web3
Beauty
Cannabis
Infrastructure
LGBT
Celebrity
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Climate
Publishing
Music
Manufacturing
Art
Real Estate
Sporting Goods
Digital Media
Financial Services
FinTech
Social Media
Franchise
Finance
Mobile Advertising
Android
Non Profit
Internet
Sustainability
Enterprise
Hardware
Biotech
Impact
Proptech
Community
Transportation
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Sudan
Andorra
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Paraguay
Botswana
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Canada
United Kingdom
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Angola
Europe
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Bangladesh
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Hungary
Belarus
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Simon Fiduciaria, VC Fund

Simon Fiduciaria

VC Fund

Turin, Italy

Simon Fiduciaria is a VC fund in Turin focused on Software and Health Care. Simon Fiduciaria offers fiduciary services.

Total investments:
11
Last investment:
Lead investor:
9%

Last updated:

Industries Simon Fiduciaria invests in

SoftwareHealth CareArtificial IntelligenceTherapeuticsManufacturing

Stages Simon Fiduciaria invests in

SeedPre-SeedSeries ASeries BFunding Round

Countries Simon Fiduciaria invests in

ItalyIndiaSwitzerlandUnited Kingdom

Round sizes

Seed $1.1M–$7.6MPre-Seed $614k–$1.6M

Round size

Seed
$1.1M–$7.6M
Pre-Seed
$614k–$1.6M

Investment Focus

Industry

  • Software 3 (27%)
  • Health Care 3 (27%)
  • Artificial Intelligence 3 (27%)
  • Therapeutics 2 (18%)
  • Manufacturing 2 (18%)
See all 28 industries →

Stage

  • Seed 6 (55%)
  • Pre-Seed 2 (18%)
  • Series A 1 (9%)
  • Series B 1 (9%)
  • Funding Round 1 (9%)

Country

  • Italy 8 (73%)
  • India 1 (9%)
  • Switzerland 1 (9%)
  • United Kingdom 1 (9%)

Investments

CompanyDescriptionRoundLinks
AutoConnexa AutoConnexa
Connexa InsTech is a digital and telematics insurance company solution offering unprecedented customer-centricity and flexibility. It was founded in 2021 and its headquarters is located in Bari, Apulia, Italy. $5.2M / Seed / Feb 24, 2026
Displaid Displaid
Displaid develops monitoring and management of bridges and viaducts for infrastructure network, IoT sensors, and AI algorithms. $1.4M / Seed / Jul 16, 2025
MgShell MgShell
MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures. $1.3M / Seed / Apr 30, 2025
Annaida Technologies Annaida Technologies
Annaida Technologies has developed a groundbreaking device, EmbryoSpin, that performs microscopic Nuclear Magnetic Resonance (“µNMR”) at a scale 10-fold better than existing technologies. Seed / Apr 29, 2025
Soource Soource
Soource is a B2B Saas product that uses AI applications to help purchasing managers to discover the best market solutions through extensive global research and automated email negotiations with thousands of suppliers worldwide. $1.6M / Pre-Seed / Jan 21, 2025
Yoyomove Yoyomove
Yoyomove is a long-term car rental company that offers long-term vehicle rental and flexible mobility solutions designed to simplify your everyday journeys $1.1M / Seed / Oct 17, 2024
AIKO - Infinite Ways to Autonomy AIKO - Infinite Ways to Autonomy
Aiko develops and commercializes algorithms based on Artificial Intelligence to increase the autonomy of satellite missions. $4.4M / Series A / Oct 09, 2024
Inventio.AI Inventio.AI
Inventio.AI is a software development company that provides artificial intelligence tools and solutions for machines and productions. $614.1K / Pre-Seed / Oct 01, 2024
Even Even
Even is a health tech company and healthcare provider that partners directly with the top hospitals in the country to offer you unlimited diagnostics, consultations, and 50 lakh worth of hospitalisations all with one monthly subscription cost. $20.1M / Venture - Series Unknown / Aug 21, 2024
NeoPhore NeoPhore
NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.The company's small molecule therapies target genetic mechanisms in order to create neoantigen which is known to stimulate the immune system and potentially be a weak spot in a tumor cell's defense mechanisms,enabling cancer patients to get treated and achieve improved clinical outcomes. $12.2M / Series B / Feb 01, 2024
See all 11 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Social Impact
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Hospitality
Automotive
Sports
Biotechnology
Legal
Consumer
Software
eSports
Construction
Crowdfunding
Renewable Energy
Venture Capital
Theatre
Fashion
Medical
Recruiting
Social
Web3
Beauty
Cannabis
Infrastructure
LGBT
Celebrity
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Climate
Publishing
Music
Manufacturing
Art
Real Estate
Sporting Goods
Digital Media
Financial Services
FinTech
Social Media
Franchise
Finance
Mobile Advertising
Android
Non Profit
Internet
Sustainability
Enterprise
Hardware
Biotech
Impact
Proptech
Community
Transportation
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Sudan
Andorra
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Paraguay
Botswana
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Canada
United Kingdom
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Angola
Europe
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Bangladesh
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Hungary
Belarus
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Simon Fiduciaria invest in?

Simon Fiduciaria invests primarily in Software, Health Care and Artificial Intelligence startups, most often at Seed and Pre-Seed stage. Most of the 11 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Simon Fiduciaria's check size?

Simon Fiduciaria typically joins rounds of $1.1M–$7.6M at Seed and $614k–$1.6M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Simon Fiduciaria participates in.

When did Simon Fiduciaria last invest?

The most recent investment recorded for Simon Fiduciaria closed in Feb 2026. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Simon Fiduciaria Simon Fiduciaria Find emails